Aileron Therapeutics Stock (NASDAQ: ALRN) stock price, news, charts, stock research, profile.
Open | $2.81 |
Close | $2.84 |
Volume / Avg. | 18.18K / 110.37K |
Day Range | 2.72 - 2.87 |
52 Wk Range | 1.01 - 7.42 |
Market Cap | $60.02M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 0.71% |
Days to Cover | 2.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aileron Therapeutics (NASDAQ:ALRN) through any online brokerage.
Other companies in Aileron Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Intensity Therapeutics (NASDAQ:INTS), CARISMA Therapeutics (NASDAQ:CARM), Burning Rock Biotech (NASDAQ:BNR) and Barinthus Biotherapeutics (NASDAQ:BRNS).
There is no analysis for Aileron Therapeutics.
Aileron Therapeutics has a consensus price target of $6.67.
The stock price for Aileron Therapeutics (NASDAQ: ALRN) is $2.84 last updated July 3, 2024 at 12:59 PM EDT.
There are no upcoming dividends for Aileron Therapeutics.
Aileron Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Aileron Therapeutics.
Aileron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.